Green dye test in repeat weight loss surgery
Part of Hormones & metabolism clinical trials.
This trial tests if a green dye, injected during repeat weight loss surgery, helps surgeons see blood flow better. It may reduce complications for people having a second bariatric procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have obesity with a BMI of 30 or higher
- You are scheduled for a repeat (revisional) bariatric surgery
- You do not have an allergy to iodides or certain blood thinners
- You have not had radioactive iodine tests in the past week
- You are not pregnant, breastfeeding, or planning pregnancy in the next year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special green dye that helps surgeons see blood flow in the bowel during surgery. It may help reduce complications after removing part of the bowel for diseases like cancer or diverticulitis.
This trial tests whether a green dye called indocyanine green can help surgeons find and remove more lymph nodes during laparoscopic surgery for advanced stomach cancer. It may improve the chances of removing all cancer.
This trial compares two dyes used during stomach or intestine surgery to see which helps surgeons see the blood flow better. It may help decide which dye works best for safe reconnections.
This study tests whether using a green dye during emergency gallbladder removal helps surgeons see the bile ducts more clearly, which may reduce complications. If you are having urgent gallbladder surgery, this could make your operation safer.
This trial tests whether a special fluorescent dye called indocyanine green (ICG) can help surgeons see better during laparoscopic Heller-Dor surgery for achalasia. It may improve the safety and success of the procedure.
This Phase 2 study tests whether using a special light-activated dye (indocyanine green) during laparoscopic stomach surgery can improve surgical outcomes for people with remnant (leftover) stomach cancer that has not spread to distant organs. It may help surgeons better find lymph nodes while operating.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.